These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24231201)

  • 1. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis.
    Coghill DR; Seth S; Pedroso S; Usala T; Currie J; Gagliano A
    Biol Psychiatry; 2014 Oct; 76(8):603-15. PubMed ID: 24231201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: Dose-Dependent Effects of Methylphenidate on Neurocognitive Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
    Vertessen K; Luman M; Staff A; Bet P; de Vries R; Twisk J; Oosterlaan J
    J Am Acad Child Adolesc Psychiatry; 2022 May; 61(5):626-646. PubMed ID: 34534624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.
    Liu Q; Zhang H; Fang Q; Qin L
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):854-865. PubMed ID: 28052720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
    Pasini A; Sinibaldi L; Paloscia C; Douzgou S; Pitzianti MB; Romeo E; Curatolo P; Pizzuti A
    Eur J Paediatr Neurol; 2013 Jul; 17(4):407-14. PubMed ID: 23541676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylphenidate on memory functions of adults with ADHD.
    Fuermaier AB; Tucha L; Koerts J; Weisbrod M; Lange KW; Aschenbrenner S; Tucha O
    Appl Neuropsychol Adult; 2017; 24(3):199-211. PubMed ID: 27088304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.
    Storebø OJ; Krogh HB; Ramstad E; Moreira-Maia CR; Holmskov M; Skoog M; Nilausen TD; Magnusson FL; Zwi M; Gillies D; Rosendal S; Groth C; Rasmussen KB; Gauci D; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    BMJ; 2015 Nov; 351():h5203. PubMed ID: 26608309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
    Idema IME; Payne JM; Coghill D
    J Consult Clin Psychol; 2021 Jul; 89(7):615-625. PubMed ID: 34383534
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies.
    Jin C; Schachar R
    CNS Spectr; 2004 Mar; 9(3):217-26. PubMed ID: 14999162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis.
    Tamminga HG; Reneman L; Huizenga HM; Geurts HM
    Psychol Med; 2016 Jul; 46(9):1791-807. PubMed ID: 27019103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis.
    Stuhec M; Lukić P; Locatelli I
    Ann Pharmacother; 2019 Feb; 53(2):121-133. PubMed ID: 30117329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
    Roskell NS; Setyawan J; Zimovetz EA; Hodgkins P
    Curr Med Res Opin; 2014 Aug; 30(8):1673-85. PubMed ID: 24627974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.
    Hammerness P; Fried R; Petty C; Meller B; Biederman J
    Child Neuropsychol; 2014; 20(3):319-27. PubMed ID: 23639146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate.
    Slama H; Fery P; Verheulpen D; Vanzeveren N; Van Bogaert P
    J Child Neurol; 2015 Jul; 30(8):1000-9. PubMed ID: 25296928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).
    Advokat C
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1256-66. PubMed ID: 20381522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials.
    Cortese S; Ferrin M; Brandeis D; Buitelaar J; Daley D; Dittmann RW; Holtmann M; Santosh P; Stevenson J; Stringaris A; Zuddas A; Sonuga-Barke EJ;
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):164-74. PubMed ID: 25721181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.